Defense Facility Still Too Risky

A second risk assessment of a proposed bio-defense laboratory shows major improvement, but still has serious flaws, according to an independent review panel.

Written byHayley Dunning
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, CREATIVE COMMONS, BEATRICE MURCH

After a largely negative review in 2010, the National Bio- and Agro-Defense Facility is back on the right track, though more progress is needed before it can officially open its doors, according to an independent National Academy of Sciences (NAS) review panel.

The facility, which would be the highest biosafety level lab in the country, has drawn criticism for its risk of releasing dangerous pathogens into the surrounding cattle-dense region of Manhattan, Kansas. Of particular concern is the release of foot and mouth disease, which can decimate cattle and other cloven-footed animals. The US Department of Homeland Security released an assessment in 2010 that, when analyzed by an independent review panel, put the risk of releasing infectious diseases like foot and mouth at 70 percent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies